To describe cervical cancer screening (CCS) patterns from 2019 through 2024 across race and ethnicity, age, language, and US Census region, including the COVID-19 pandemic period.
Approach:
Design and data: Retrospective cross-sectional study using preaggregated, deidentified Epic Cosmos electronic medical record data.
Population: Patients assigned female at birth, aged 21 to 64 years, with at least one clinical encounter in each year from 2019 through 2024 and no history of cervical cancer.
Screening measure: Annual CCS rates were calculated from eligible patients screened at least once in the corresponding year, using ICD-10, CPT, and HCPCS codes.
Comparisons: Rates were examined descriptively by race and ethnicity, age group, English versus other language, and US Census region.
Interpretation:
The supplied context describes the study’s objective and methods but does not report its results.
Limitations:
The supplied context does not include the study’s results or a complete limitations section.
Harold Burstein, MD, PhD, and Rachel Freedman, MD, MPH discuss the results of a new study looking at the impact of food access and poverty on patients with metastatic breast cancer. They also discuss the new Dana-Farber food pantry and patient navigators who help coordinate care.
